Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122007713 | 12200771 | 3 | F | 201602 | 20160628 | 20160322 | 20160713 | EXP | FR-DSJP-DSE-2016-110247 | DAIICHI | 0.00 | Y | 0.00000 | 20160713 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122007713 | 12200771 | 1 | PS | ALTEISDUO | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | UNK | Y | 21532 | FILM-COATED TABLET | ||||||||
| 122007713 | 12200771 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122007713 | 12200771 | 1 | Hypertension |
| 122007713 | 12200771 | 2 | Dyslipidaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122007713 | 12200771 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122007713 | 12200771 | Interstitial lung disease | |
| 122007713 | 12200771 | Muscular weakness | |
| 122007713 | 12200771 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122007713 | 12200771 | 1 | 2012 | 20160222 | 0 | |
| 122007713 | 12200771 | 2 | 2012 | 20160210 | 0 |